Saturday, 31 October 2026 Every NSE & BSE announcement, by company
ALFA Filings Every announcement, straight from the exchange
Legal & Regulatory

Titan Biotech Legal & Regulatory

Titan Biotech reported loss of 300 shares previously transferred to the IEPF. Claims must be submitted within 15 days as per Regulation 39(3).

Source

BSE filing, NSE: TITANBIO. Summary written from the filing by ALFA Finder's alert engine.

Read the filing ↗

Titan Biotech Ltd: key numbers

Share price
₹339.85
Market cap
₹1,755 Cr
Revenue (annual)
₹206.2 Cr
Net profit (annual)
₹29.89 Cr
P/E (TTM)
51.8×Sector 34.1×
Promoter holding
55.78%+0.00% QoQ
FII holding
0.00%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

More from Titan Biotech Ltd

All →

Other legal & regulatory announcements

All →